Peter M. Elias
Technik-/Wissenschafts-/F&E-Leiter bei Ceragenix Corp.
Aktive Positionen von Peter M. Elias
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Ceragenix Corp. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2004 | - |
Karriereverlauf von Peter M. Elias
Ehemalige bekannte Positionen von Peter M. Elias
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OnSource Corp. | Technik-/Wissenschafts-/F&E-Leiter | - | 27.06.2005 |
Ceragenix Pharmaceuticals, Inc.
 Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2005 | - |
Ausbildung von Peter M. Elias
| Stanford University | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| OnSource Corp. | Consumer Services |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
| Ceragenix Corp. |
- Börse
- Insiders
- Peter M. Elias
- Erfahrung
